Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026
BioPharma Dive
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what s been observed over a similar timeframe in prior years, according to
pharminent
March 31, 2026 (Last updated: March 31, 2026)
BioPharma Dive
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what s been observed over a similar timeframe in prior years, according to
